Scandinavian ChemoTech AB (publ) (CMOTEC-B.ST)

SEK 1.48

(0.68%)

Eps Summary of Scandinavian ChemoTech AB (publ)

  • Scandinavian ChemoTech AB (publ)'s latest annual eps in 2023 was -1.13 SEK , up 36.84% from previous year.
  • Scandinavian ChemoTech AB (publ)'s latest quarterly eps in 2024 Q1 was -0.18 SEK , up 48.57% from previous quarter.
  • Scandinavian ChemoTech AB (publ) reported an annual eps of -2.47 SEK in 2022, down -15.96% from previous year.
  • Scandinavian ChemoTech AB (publ) reported an annual eps of -2.13 SEK in 2021, up 16.14% from previous year.
  • Scandinavian ChemoTech AB (publ) reported a quarterly eps of -0.18 SEK for 2024 Q1, up 48.57% from previous quarter.
  • Scandinavian ChemoTech AB (publ) reported a quarterly eps of -0.48 SEK for 2023 Q2, down -11.63% from previous quarter.

Annual Eps Chart of Scandinavian ChemoTech AB (publ) (2023 - 2013)

Historical Annual Eps of Scandinavian ChemoTech AB (publ) (2023 - 2013)

Year Eps Eps Growth
2023 -1.13 SEK 36.84%
2022 -2.47 SEK -15.96%
2021 -2.13 SEK 16.14%
2020 -2.54 SEK 16.99%
2019 -3.06 SEK -108.16%
2018 -1.47 SEK 74.21%
2017 -5.70 SEK -2.33%
2016 -5.57 SEK -440.78%
2015 -1.03 SEK -4138.68%
2014 -0.02 SEK -305.0%
2013 -0.01 SEK 0.0%

Peer Eps Comparison of Scandinavian ChemoTech AB (publ)

Name Eps Eps Difference
Alligator Bioscience AB (publ) -0.55 SEK -105.455%
Ziccum AB (publ) -1.54 SEK 26.623%
Modus Therapeutics Holding AB (publ) -1.01 SEK -11.881%
BioArctic AB (publ) 2.60 SEK 143.462%
Sprint Bioscience AB (publ) -0.01 SEK -17836.508%
Mendus AB (publ) -4.40 SEK 74.318%
Genovis AB (publ.) 0.94 SEK 220.213%
Intervacc AB (publ) -1.69 SEK 33.136%
QuiaPEG Pharmaceuticals Holding AB (publ) -0.22 SEK -413.636%
Active Biotech AB (publ) -0.17 SEK -564.706%
Magle Chemoswed Holding AB (publ) 1.13 SEK 200.0%
Bio-Works Technologies AB (publ) -1.57 SEK 28.025%
Aptahem AB (publ) -0.05 SEK -2239.545%
Vicore Pharma Holding AB (publ) -3.22 SEK 64.907%
Kancera AB (publ) -0.80 SEK -41.25%
Infant Bacterial Therapeutics AB (publ) -9.95 SEK 88.643%
Fluicell AB (publ) -0.24 SEK -370.833%
Saniona AB (publ) -1.29 SEK 12.403%
Lipigon Pharmaceuticals AB (publ) -0.19 SEK -494.737%
Biovica International AB (publ) -2.14 SEK 47.196%
Spago Nanomedical AB (publ) -0.43 SEK -162.791%
AcouSort AB (publ) -1.29 SEK 12.403%
Xintela AB (publ) -0.13 SEK -769.231%
Abliva AB (publ) -0.09 SEK -1150.0%
Egetis Therapeutics AB (publ) -1.27 SEK 11.024%
Karolinska Development AB (publ) 0.02 SEK 5750.0%
OncoZenge AB (publ) -1.36 SEK 16.912%
Amniotics AB (publ) -0.01 SEK -10172.727%
2cureX AB (publ) -1.85 SEK 38.919%
CombiGene AB (publ) -1.80 SEK 37.222%
Asarina Pharma AB (publ) -0.57 SEK -98.246%
Calliditas Therapeutics AB (publ) -8.69 SEK 86.997%
Camurus AB (publ) 7.78 SEK 114.524%
Corline Biomedical AB -0.08 SEK -1242.043%
IRLAB Therapeutics AB (publ) -3.43 SEK 67.055%
Isofol Medical AB (publ) -0.23 SEK -391.304%
I-Tech AB 1.70 SEK 166.471%
Hansa Biopharma AB (publ) -15.83 SEK 92.862%
Cyxone AB (publ) -0.22 SEK -413.636%
ExpreS2ion Biotech Holding AB (publ) -1.98 SEK 42.929%
Biosergen AB -0.60 SEK -88.333%
Cantargia AB (publ) -1.65 SEK 31.515%
NextCell Pharma AB -1.03 SEK -9.709%
Xspray Pharma AB (publ) -6.76 SEK 83.284%
Elicera Therapeutics AB (publ) -0.83 SEK -36.145%
Nanologica AB (publ) -2.05 SEK 44.878%
SynAct Pharma AB -6.64 SEK 82.982%
Annexin Pharmaceuticals AB (publ) -0.26 SEK -334.615%
Stayble Therapeutics AB (publ) -0.92 SEK -22.826%
LIDDS AB (publ) -0.63 SEK -79.365%
Lipum AB (publ) -4.45 SEK 74.607%
BioInvent International AB (publ) -5.02 SEK 77.49%
Alzinova AB (publ) -0.41 SEK -175.61%
Oncopeptides AB (publ) -1.96 SEK 42.347%
Pila Pharma AB (publ) -0.47 SEK -140.426%
Guard Therapeutics International AB (publ) -11.26 SEK 89.964%
Simris Alg AB (publ) -0.16 SEK -606.25%
Diamyd Medical AB (publ) -1.60 SEK 29.375%
Xbrane Biopharma AB (publ) -1.27 SEK 11.024%
Ascelia Pharma AB (publ) -3.24 SEK 65.123%
Diagonal Bio AB (publ) -0.32 SEK -253.125%